黄半脱酶缺乏症:一种代谢和基因组方法来诊断
Kevin E Glinton1, Charul Gijavanekar1, Abbhirami Rajagopal1
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
Frontiers in genetics
|July 16, 2024
概括
这项研究确定了16名患有黄半脱酶缺乏症 (SSADHD) 的患者,这是一种罕见的神经代谢障碍. 使用分子,临床和代谢学数据的综合方法使得诊断速度更快,并可能被纳入新生儿查.
科学领域:
- 遗传学和基因组学 在
- 神经代谢障碍 神经代谢障碍
- 生物化学 生物化学
背景情况:
- 基因组测序有助于基因诊断,但具有不确定的意义的变体和未被诊断的神经代谢状况,如GABA催化过程中的变体,会带来挑战.
- 黄半脱酶缺乏症 (SSADHD) 是一种罕见的GABA途径的神经代谢障碍,由ALDH5A1的变异引起,通常呈现出严重的发育和神经症状.
- 未被诊断的病例,特别是未分化表型的病例,导致SSADHD和相关的GABA相关疾病的诊断不足.
研究的目的:
- 利用分子,临床和代谢学数据开发SSADHD的综合诊断方法.
- 识别新型致病变体并评估SSADHD的全球流行率.
- 建立改善诊断,潜在的新生儿查和改善患者治疗结果的途径.
主要方法:
- 来自大型商业实验室的分子,临床和代谢数据的综合分析.
- 鉴定和描述可能患有SSADHD的患者,包括新型变异.
- 对现有的致病性/可能致病性变体的调查,以估计全球疾病流行率.
主要成果:
- 确定了16名可能患有SSADHD的患者,包括三个新型变体.
- 表明与SSADHD相关的明显的代谢特征.
- 基于变体数据的SSADHD全球流行率的估计.
结论:
- 结合分子,临床和新陈代谢数据的综合诊断方法有助于有效的SSADHD诊断.
- 早期诊断SSADHD通过遗传咨询,家庭支持和向治疗来改善患者的结果.
- 这些发现支持将SSADHD诊断纳入新生儿查计划,以便及时干预.
相关概念视频
01:20Inborn Errors of Metabolism
153
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
153
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K